Clinical trial
Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion.
NCT00232219 is registered in ClinicalTrials.gov with Melbourne Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion.
- Lead sponsor
- Melbourne Health
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2003
- Completion date
- November 30, 2013
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.